Intratonsillar immunotherapy (ITIT) is a novel AIT approach, which directly inject allergens into tonsillar tissue to induce both local and systemic immune tolerance
The most common adverse effects from the SURMOUNT trials include: Nausea: 24-33% of participants (dose-dependent) Diarrhea: 18-25% of participants Constipation: 13-17% of participants Vomiting: 8-12% of participants Decreased appetite: 10-15% of participants Most of these effects are mild to moderate and occur primarily during dose escalation periods
Arsenic and chromium induced toxicity on zebrafish kidney: mixture effects on oxidative stress and involvement of nrf2-keap1-are, DNA repair, and intrinsic apoptotic pathways
Privacy: Manage your routine in the comfort of your own space
O Srum GHK-Cu 3% um srum facial de alta performance formulado com GHK-Cu (Peptdeo de Cobre), um dos ativos mais estudados no universo do cuidado antiaging
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19
